Detalhe da pesquisa
1.
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN trials.
Hepatology
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630448
2.
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
J Hepatol
; 80(1): 20-30, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734683
3.
Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection.
Clin Gastroenterol Hepatol
; 21(6): 1503-1512.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35843468
4.
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 20(6): 1343-1353.e16, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500103
5.
Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.
Gut
; 68(6): 1088-1098, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064987
6.
Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis.
J Gastroenterol Hepatol
; 31(11): 1851-1859, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26990109
7.
Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
J Gastroenterol Hepatol
; 31(6): 1168-76, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26647353
8.
Factors associated with knowledge and awareness of Hepatitis B in individuals of Chinese descent: Results from a mass point of care testing and outreach campaign in Toronto, Canada.
Can Liver J
; 7(1): 28-39, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38505784
9.
Province-to-province variability in hepatitis C testing, care, and treatment across Canada.
Can Liver J
; 6(2): 234-248, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503520
10.
Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells.
J Clin Invest
; 133(1)2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594467
11.
Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario.
Can Liver J
; 5(3): 362-371, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36133900
12.
Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.
JCI Insight
; 6(7)2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621209
13.
Hepatitis B core-related antigen levels predict pegylated interferon-α therapy response in HBeAg-positive chronic hepatitis B.
Antivir Ther
; 25(4): 217-222, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744512
14.
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
Antivir Ther
; 12(8): 1285-94, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18240868
15.
GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo.
Oncoimmunology
; 4(12): e1051297, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26587321
16.
Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors.
Oncoimmunology
; 4(6): e1008355, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26155417